ChiCTR1800017706 2018.

Study name	Elderly patients multi‐drug management: a multicenter randomized controlled trial
Methods	Cluster‐randomisation; in this study, a third‐party randomisation method was used to allocate 5 centres: 2 centres as control group and 3 centres as intervention group
Participants	Inclusion criteria: Aged 65 to 85 years old Hypertension, hyperlipidaemia, coronary heart disease, cerebral infarction, diabetes patients in Cardiology Department, cerebral infarction ward of Neurology Department and Endocrinology Department Using more than 5 oral medications for cardio‐cerebrovascular systems and diabetes Patients volunteered to merge and sign the informed consent Exclusion criteria: Patients with cancer, blood system diseases and other serious diseases or life expectancy less than 1 year Taking non‐cardio‐cerebrovascular or non‐diabetic drugs such as respiratory and digestive systems medications at the same time Patients who stay in ICU Peri‐operative patients Patients with hearing loss, mental retardation, severe visual impairment and other factors that affect the quality of follow‐up
Interventions	Pharmacists intervention with aid of intelligentialised medication review system
Outcomes	Incidence of potentially inappropriate medication use Drug compliance Blood pressure Total cholesterol Low density lipoprotein Triglyceride Blood glucose
Starting date	January 2019
Contact information	Study leader: Yan Suying; email: yansuying10@xwhosp.org; phone: +86 13708905057
Notes	Chinese Clinical Trial Registry (accessed February 2020) Trial ID: ChiCTR1800017706